Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia
Condition(s):LeukemiaLast Updated:February 15, 2019Completed
Hide Studies Not Open or Pending
Condition(s):LeukemiaLast Updated:February 15, 2019Completed
Condition(s):LeukemiaLast Updated:August 7, 2013Unknown status
Condition(s):LeukemiaLast Updated:September 17, 2013Unknown status
Condition(s):LeukemiaLast Updated:December 4, 2013Unknown status
Condition(s):Leukemia; LymphomaLast Updated:July 24, 2014Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:February 1, 2013Withdrawn
Condition(s):Acute Myeloid Leukemia, Adult; Myelodysplastic Syndromes, AdultLast Updated:January 10, 2024Not yet recruiting
Condition(s):Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Thymic CarcinomaLast Updated:March 7, 2011Completed
Condition(s):Leukemia; LymphomaLast Updated:June 12, 2013Completed
Condition(s):Chronic Myeloproliferative Disorders; Diamond-blackfan Anemia; Fanconi Anemia; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative DiseasesLast Updated:November 29, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.